Acholeplasma hippikon Details: NCBI 264636, gram-negative or unknown [species]

| Acholeplasma hippikon| Acholeplasma hippikon Kirchoff 1974| ATCC 29725| NCTC 10172| strain C1

  1. Commensal and Opportunistic Nature: Acholeplasma species, including Acholeplasma hippikon, are often considered commensal bacteria, meaning they can be part of the normal microbial flora in various environments, including the respiratory and urogenital tracts in humans. However, under certain conditions, they may also act as opportunistic pathogens.

  2. Association with Animals: Some Acholeplasma species have been associated with respiratory infections in animals, including cattle and pigs. Acholeplasmas are known to colonize mucosal surfaces and can be involved in respiratory diseases in animals.

  3. Human Microbiota: Acholeplasma species have been identified in the human microbiota, particularly in the respiratory and urogenital tracts. However, their role in human health and disease is not as well-characterized as some other bacteria.

  4. Clinical Significance: The clinical significance of Acholeplasma hippikon and its potential health impacts in humans or animals may depend on factors such as the host's immune status, the presence of other microorganisms, and the specific conditions of the host environment.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Acholeplasma hippikon

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.26 2 50 0 55 21.3 20 17.4 2 50 12.5 %ile 75 %ile
biomesight 23.13 0 20 10 400 0 3149 442.6 70 1380.7 0 490 0 %ile 90.9 %ile
thorne 37.93 1 9 0 9 4.4 4 2.6 1 9 7.7 %ile 84.6 %ile
thryve 34.39 0 17 14 45 0 75 32 27 22 9 51 8 %ile 92 %ile

External Reference Ranges for Acholeplasma hippikon

Acholeplasma hippikon (NCBI 264636) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Acholeplasma hippikon
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 24.975 %   0.042 %  0.128 % 740.0 2963
BiomeSightRdp 9.677 %   0.01 %  0.013 % 3.0 31
CerbaLab 66.667 %   0 %  0 % 2.0 3
es-xenogene 6.897 %   0.004 %  0.001 % 2.0 29
Thorne 25 %   0 %  0 % 26.0 104
Thryve 36.835 %   0.003 %  0.002 % 512.0 1390

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Probiotics bacillus amyloliquefaciens (probiotic) 1 Studies recorded. The consensus is Decreases📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.